In this issue:
- Global burden, risk factors, and temporal trends of ureteral cancer
- Epacadostat + pembrolizumab for advanced urothelial carcinoma
- Short course ADT + postoperative radiotherapy for prostate cancer
- Long- vs short-course ADT + post-operative radiotherapy for prostate cancer
- Immunotherapy-based combinations for urothelial cancer
- Radiotherapy + pembrolizumab for advanced urothelial carcinoma
- Immunotherapy and cytoreductive nephrectomy in mRCC
- Immuno-oncology combination therapy for metastatic non-clear cell RCC
- Fertility prognosis in testicular cancer after oncological treatments
- Neoadjuvant chemotherapy + RC in octogenarians with MIBC
Please login below to download this issue (PDF)